Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.260
+0.060 (5.00%)
At close: Jul 3, 2025, 1:00 PM
1.280
+0.020 (1.59%)
After-hours: Jul 3, 2025, 4:36 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $77.35 million as of July 3, 2025. Its market cap has decreased by -89.13% in one year.
Market Cap
77.35M
Enterprise Value
-168.12M
1-Year Change
-89.13%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $77.35M, a decrease of -89.51%. That is a compound annual growth rate of -35.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 73.66M | -90.81% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |